The Directorate of Revenue Intelligence (DRI) has busted an illicit laboratory manufacturing alprazolam in Delhi's Ghazipur area, seizing 148 kg of alprazolam intermediate and arresting the person operating the facility, according to an agency statement issued through the Press Information Bureau on Wednesday.

Officers searched the premises on 15 and 16 November 2026, the DRI said. The search revealed a fully functional clandestine laboratory equipped with reaction apparatus, a water chiller, a vacuum exhaust machine and other manufacturing equipment. The premises were reportedly operating under the façade of a computer shop, which concealed a complete manufacturing setup for the drug.

Besides the 148 kg of alprazolam intermediate in solid and liquid form, officers seized approximately 1,046 kg of raw materials and chemicals, along with 188 litres of additional chemicals and liquids used in the process. The equipment and materials were seized under the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985. The DRI did not name the accused.

Alprazolam is a benzodiazepine-class psychotropic substance, commonly sold under brand names such as Xanax and Alprax, and is a prescription medicine used mainly for anxiety and panic disorders. It is a notified psychotropic substance under the NDPS Act, and its unauthorised manufacture, possession, sale and distribution attract penal provisions.

The DRI described the operation as intelligence-led and said the Delhi bust came within weeks of its 29 October 2026 operation in Uttar Pradesh's Jalaun district, where a clandestine synthetic drug laboratory was dismantled with assistance from the UP Anti-Terrorism Squad. That operation led to the seizure of about 1,100 kg of drugs and precursor chemicals and the arrest of two persons.